Clinical Trial Update: Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis [Phase 3]

View source ↗

Summary

Phase 3 study assessing the effect of mipomersen on LDL-cholesterol levels in patients treated by regular apheresis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Ldl-hypercholesterolemia

Drugs mentioned

• Kynamro (mipomersen)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Atherosclerosis, LDL-hypercholesterolemia | Phase 3 | Status: COMPLETED